Clonidine Hydrochloride Tablet
NDC 70518-4342
Product Information
Clonidine Hydrochloride is a ANDA-approved product labeled by Remedyrepack Inc.. This medication is typically used as a adrenergic alpha2-agonists [moa]. It is supplied as a orange tablet for oral administration. This product entry covers the primary NDC 70518-4342 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
R127
Code Structure Chart
Product Details
What is NDC 70518-4342?
What are the uses of this product?
What are Active Ingredients of this product?
- CLONIDINE HYDROCHLORIDE .1 mg/1 - An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CLONIDINE HYDROCHLORIDE (UNII: W76I6XXF06)
- CLONIDINE (UNII: MN3L5RMN02) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- STARCH, CORN (UNII: O8232NY3SJ)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- D&C YELLOW NO. 10 ALUMINUM LAKE (UNII: CQ3XH3DET6)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 884173 - cloNIDine HCl 0.1 MG Oral Tablet
- RxCUI: 884173 - clonidine hydrochloride 0.1 MG Oral Tablet
- RxCUI: 884173 - clonidine HCl 100 MCG Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.